Hiroshi Miyamoto, M.D., Ph.D.

Hiroshi Miyamoto, M.D., Ph.D.

Contact Information

University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 626
Rochester, NY 14642

Office: (585) 275-8748
Lab: (585) 275-1739
Administrative: (585) 275-3191
Fax: (585) 273-3637

Journal Articles

Showing all 156 journal articles available.

2016 Jul 18
Kawahara T, Inoue S, Ide H, Kashiwagi E, Ohtake S, Mizushima T, Li P, Li Y, Zheng Y, Uemura H, Netto GJ, Ishiguro H, Miyamoto H. "ZKSCAN3 promotes bladder cancer cell proliferation, migration, and invasion." Oncotarget. 2016 Jul 18; Epub 2016 Jul 18.
2016 Jun 18
Kawahara T, Ide H, Kashiwagi E, El-Shishtawy KA, Li Y, Reis LO, Zheng Y, Miyamoto H. "Enzalutamide inhibits androgen receptor-positive bladder cancer cell growth." Urologic oncology. 2016 Jun 18; Epub 2016 Jun 18.
2016 Jun 14
Kashiwagi E, Ide H, Inoue S, Kawahara T, Zheng Y, Reis LO, Baras AS, Miyamoto H. "Androgen receptor activity modulates responses to cisplatin treatment in bladder cancer." Oncotarget. 2016 Jun 14; Epub 2016 Jun 14.
2016 Jun
Kawahara T, Miyamoto H, Ito H, Terao H, Kakizoe M, Kato Y, Ishiguro H, Uemura H, Yao M, Matsuzaki J. "Predicting the mineral composition of ureteral stone using non-contrast computed tomography." Urolithiasis. 2016 Jun; 44(3):231-9. Epub 2015 Oct 01.
2016 Jun
Kawahara T, Aljarah AK, Shareef HK, Inoue S, Ide H, Patterson JD, Kashiwagi E, Han B, Li Y, Zheng Y, Miyamoto H. "Silodosin inhibits prostate cancer cell growth via ELK1 inactivation and enhances the cytotoxic activity of gemcitabine." The Prostate. 2016 Jun; 76(8):744-56. Epub 2016 Feb 11.
2016 Apr 26
Silvers CR, Liu YR, Wu CH, Miyamoto H, Messing EM, Lee YF. "Identification of extracellular vesicle-borne periostin as a feature of muscle-invasive bladder cancer." Oncotarget. 2016 Apr 26; 7(17):23335-45.
2016 Mar 22
Izumi K, Ito Y, Miyamoto H, Miyoshi Y, Ota J, Moriyama M, Murai T, Hayashi H, Inayama Y, Ohashi K, Yao M, Uemura H. "Expression of androgen receptor in non-muscle-invasive bladder cancer predicts the preventive effect of androgen deprivation therapy on tumor recurrence." Oncotarget. 2016 Mar 22; 7(12):14153-60.
2016 Feb 16
Izumi K, Mizokami A, Lin HP, Ho HM, Iwamoto H, Maolake A, Natsagdorj A, Kitagawa Y, Kadono Y, Miyamoto H, Huang CK, Namiki M, Lin WJ. "Serum chemokine (CC motif) ligand 2 level as a diagnostic, predictive, and prognostic biomarker for prostate cancer." Oncotarget. 2016 Feb 16; 7(7):8389-98.
2016 Feb
Kawahara T, Kashiwagi E, Li Y, Zheng Y, Miyamoto Y, Netto GJ, Ishiguro H, Miyamoto H. "Cyclosporine A and tacrolimus inhibit urothelial tumorigenesis." Molecular carcinogenesis. 2016 Feb; 55(2):161-9. Epub 2015 Jan 15.
2016
Jalalizadeh M; Smith AK; Miyamoto H. "Intravesical bacillus Calmette-Guérin therapy for bladder cancer: Molecular mechanisms of action". Clinical Immunology, Endocrine & Metabolic Drugs. 2016; 3.
2016
Maeda Y, Kawahara T, Kumano Y, Ohtaka M, Kondo T, Mochizuki T, Hattori Y, Teranishi J, Miyoshi Y, Yumura Y, Miyamoto H, Yao M, Uemura H. "The Neutrophil-to-Lymphocyte Ratio before Repeat Prostate Needle Biopsy for Predicting Prostate Cancer." Urologia internationalis. 2016 96(1):123-4. Epub 2015 Dec 16.
2016
Kawahara T, Yokomizo Y, Ito Y, Ito H, Ishiguro H, Teranishi J, Makiyama K, Miyoshi Y, Miyamoto H, Yao M, Uemura H. "Pretreatment neutrophil-to-lymphocyte ratio predicts the prognosis in patients with metastatic prostate cancer." BMC cancer. 2016 16:111. Epub 2016 Feb 16.
2016
Kawahara T, Furuya K, Nakamura M, Sakamaki K, Osaka K, Ito H, Ito Y, Izumi K, Ohtake S, Miyoshi Y, Makiyama K, Nakaigawa N, Yamanaka T, Miyamoto H, Yao M, Uemura H. "Neutrophil-to-lymphocyte ratio is a prognostic marker in bladder cancer patients after radical cystectomy." BMC cancer. 2016 16:185. Epub 2016 Mar 05.
2016
Maeda Y, Kawahara T, Koizumi M, Ito H, Kumano Y, Ohtaka M, Kondo T, Mochizuki T, Hattori Y, Teranishi J, Yumura Y, Miyoshi Y, Yao M, Miyamoto H, Uemura H. "Lack of an Association between Neutrophil-to-Lymphocyte Ratio and PSA Failure of Prostate Cancer Patients Who Underwent Radical Prostatectomy." BioMed research international. 2016 2016:6197353. Epub 2016 Apr 20.
2016
Kawahara T, Fusayasu S, Izumi K, Yokomizo Y, Ito H, Ito Y, Kurita K, Furuya K, Hasumi H, Hayashi N, Myoshi Y, Miyamoto H, Yao M, Uemura H. "Bone management in Japanese patients with prostate cancer: hormonal therapy leads to an increase in the FRAX score." BMC urology. 2016 16(1):32. Epub 2016 Jun 17.
2016
Kasuga J, Kawahara T, Takamoto D, Fukui S, Tokita T, Tadenuma T, Narahara M, Fusayasu S, Terao H, Izumi K, Ito H, Hattori Y, Teranishi JI, Sasaki T, Makiyama K, Miyoshi Y, Yao M, Yumura Y, Miyamoto H, Uemura H. "Increased neutrophil-to-lymphocyte ratio is associated with disease-specific mortality in patients with penile cancer." BMC cancer. 2016 16:396. Epub 2016 Jul 07.
2015 Oct 13
Kawahara T, Fukui S, Sakamaki K, Ito Y, Ito H, Kobayashi N, Izumi K, Yokomizo Y, Miyoshi Y, Makiyama K, Nakaigawa N, Yamanaka T, Yao M, Miyamoto H, Uemura H. "Neutrophil-to-lymphocyte ratio predicts prostatic carcinoma in men undergoing needle biopsy." Oncotarget. 2015 Oct 13; 6(31):32169-76.
2015 Oct 6
Kawahara T, Shareef HK, Aljarah AK, Ide H, Li Y, Kashiwagi E, Netto GJ, Zheng Y, Miyamoto H. "ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression." Oncotarget. 2015 Oct 6; 6(30):29860-76.
2015 Oct
Zheng Y, Ishiguro H, Ide H, Inoue S, Kashiwagi E, Kawahara T, Jalalizadeh M, Reis LO, Miyamoto H. "Compound A Inhibits Bladder Cancer Growth Predominantly via Glucocorticoid Receptor Transrepression." Molecular endocrinology. 2015 Oct; 29(10):1486-97. Epub 2015 Aug 31.
2015 May
Kawahara T, Kashiwagi E, Ide H, Li Y, Zheng Y, Ishiguro H, Miyamoto H. "The role of NFATc1 in prostate cancer progression: cyclosporine A and tacrolimus inhibit cell proliferation, migration, and invasion." The Prostate. 2015 May; 75(6):573-84. Epub 2015 Jan 28.
2015 Apr
Lin SJ, Lin CY, Yang DR, Izumi K, Yan E, Niu X, Chang HC, Miyamoto H, Wang N, Li G, Chang C. "The Differential Effects of Anti-Diabetic Thiazolidinedione on Prostate Cancer Progression Are Linked to the TR4 Nuclear Receptor Expression Status." Neoplasia : an international journal for oncology research. 2015 Apr; 17(4):339-47.
2015 Jan 30
Kawahara T, Kashiwagi E, Ide H, Li Y, Zheng Y, Miyamoto Y, Netto GJ, Ishiguro H, Miyamoto H. "Cyclosporine A and tacrolimus inhibit bladder cancer growth through down-regulation of NFATc1." Oncotarget. 2015 Jan 30; 6(3):1582-93.
2015 Jan
Tian W, Guner G, Miyamoto H, Cimino-Mathews A, Gonzalez-Roibon N, Argani P, Li X, Sharma R, Subhawong AP, Rezaei K, Bivalacqua TJ, Epstein JI, Bishop JA, Netto GJ. "Utility of uroplakin II expression as a marker of urothelial carcinoma." Human pathology. 2015 Jan; 46(1):58-64. Epub 2014 Oct 02.
2015
Kawahara T, Miyamoto H, Ito H, Terao H, Uemura H, Kubota Y, Matsuzaki J. "Discolored ureteral stents: findings in urinalysis and urine culture." PloS one. 2015 10(4):e0122984. Epub 2015 Apr 07.
2015
Lin SJ, Yang DR, Wang N, Jiang M, Miyamoto H, Li G, Chang C. "TR4 nuclear receptor enhances prostate cancer initiation via altering the stem cell population and EMT signals in the PPARG-deleted prostate cells." Oncoscience. 2015 2(2):142-50. Epub 2015 Feb 09.
2015
Ishiguro H, Izumi K, Kashiwagi E, Zheng Y, Li Y, Kawahara T, Miyamoto H. "Semenogelin I promotes prostate cancer cell growth via functioning as an androgen receptor coactivator and protecting against zinc cytotoxicity." American journal of cancer research. 2015 5(2):738-47. Epub 2015 Jan 15.
2015
Yeh CR, Hsu I, Song W, Chang H, Miyamoto H, Xiao GQ, Li L, Yeh S. "Fibroblast ER? promotes bladder cancer invasion via increasing the CCL1 and IL-6 signals in the tumor microenvironment." American journal of cancer research. 2015 5(3):1146-57. Epub 2015 Feb 15.
2015
Kawahara T, Ide H, Kashiwagi E, Patterson JD, Inoue S, Shareef HK, Aljarah AK, Zheng Y, Baras AS, Miyamoto H. "Silodosin inhibits the growth of bladder cancer cells and enhances the cytotoxic activity of cisplatin via ELK1 inactivation." American journal of cancer research. 2015 5(10):2959-68. Epub 2015 Sep 15.
2015
Ide H, Miyamoto H. "Steroid Hormone Receptor Signals as Prognosticators for Urothelial Tumor." Disease markers. 2015 2015:840640. Epub 2015 Dec 07.
2014 Sep 15
Hsu I, Yeh CR, Slavin S, Miyamoto H, Netto GJ, Tsai YC, Muyan M, Wu XR, Messing EM, Guancial EA, Yeh S. "Estrogen receptor alpha prevents bladder cancer via INPP4B inhibited akt pathway in vitro and in vivo." Oncotarget. 2014 Sep 15; 5(17):7917-35.
2014 Aug
Izumi K, Lin WJ, Miyamoto H, Huang CK, Maolake A, Kitagawa Y, Kadono Y, Konaka H, Mizokami A, Namiki M. "Outcomes and predictive factors of prostate cancer patients with extremely high prostate-specific antigen level." Journal of cancer research and clinical oncology. 2014 Aug; 140(8):1413-9. Epub 2014 Apr 19.
2014 Aug
Ishiguro H, Kawahara T, Zheng Y, Kashiwagi E, Li Y, Miyamoto H. "Differential regulation of bladder cancer growth by various glucocorticoids: corticosterone and prednisone inhibit cell invasion without promoting cell proliferation or reducing cisplatin cytotoxicity." Cancer chemotherapy and pharmacology. 2014 Aug; 74(2):249-55. Epub 2014 Jun 01.
2014 Aug
Ishiguro H, Kawahara T, Zheng Y, Netto GJ, Miyamoto H. "Reduced glucocorticoid receptor expression predicts bladder tumor recurrence and progression." American journal of clinical pathology. 2014 Aug; 142(2):157-64.
2014 Jun
Slavin S, Yeh CR, Jun D, Yu S, Miyamoto H, Messing EM, Yeh S. "Estrogen receptor ? in cancer-associated fibroblasts suppresses prostate cancer invasion via modulation of thrombospondin 2 and matrix metalloproteinase 3." Carcinogenesis. 2014 Jun; 35(6):1301-9. Epub 2013 Dec 28.
2014 Jun
Lin SJ, Lee SO, Lee YF, Miyamoto H, Yang DR, Li G, Chang C. "TR4 nuclear receptor functions as a tumor suppressor for prostate tumorigenesis via modulation of DNA damage/repair system." Carcinogenesis. 2014 Jun; 35(6):1399-406. Epub 2014 Feb 28.
2014 Apr
Izumi K, Li Y, Ishiguro H, Zheng Y, Yao JL, Netto GJ, Miyamoto H. "Expression of UDP-glucuronosyltransferase 1A in bladder cancer: association with prognosis and regulation by estrogen." Molecular carcinogenesis. 2014 Apr; 53(4):314-24. Epub 2012 Nov 09.
2014 Apr
Li Y, Ishiguro H, Kawahara T, Kashiwagi E, Izumi K, Miyamoto H. "Loss of GATA3 in bladder cancer promotes cell migration and invasion." Cancer biology & therapy. 2014 Apr; 15(4):428-35. Epub 2014 Jan 21.
2014
Izumi K, Taguri M, Miyamoto H, Hara Y, Kishida T, Chiba K, Murai T, Hirai K, Suzuki K, Fujinami K, Ueki T, Udagawa K, Kitami K, Moriyama M, Miyoshi Y, Tsuchiya F, Ikeda I, Kobayashi K, Sato M, Morita S, Noguchi K, Uemura H. "Androgen deprivation therapy prevents bladder cancer recurrence." Oncotarget. 2014 5(24):12665-74.
2014
Kawahara T; Miyamoto H. "Androgen receptor antagonists in the treatment of prostate cancer". Clinical Immunology, Endocrine & Metabolic Drugs. 2014; 1(1): 11-19.
2014
Li Y, Ishiguro H, Kawahara T, Miyamoto Y, Izumi K, Miyamoto H. "GATA3 in the urinary bladder: suppression of neoplastic transformation and down-regulation by androgens." American journal of cancer research. 2014 4(5):461-73. Epub 2014 Sep 06.
2013 Oct
Srigley JR, Delahunt B, Eble JN, Egevad L, Epstein JI, Grignon D, Hes O, Moch H, Montironi R, Tickoo SK, Zhou M, Argani P, . "The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia." The American journal of surgical pathology. 2013 Oct; 37(10):1469-89.
2013 Oct
Delahunt B, Cheville JC, Martignoni G, Humphrey PA, Magi-Galluzzi C, McKenney J, Egevad L, Algaba F, Moch H, Grignon DJ, Montironi R, Srigley JR, . "The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters." The American journal of surgical pathology. 2013 Oct; 37(10):1490-504.
2013 Oct
Trpkov K, Grignon DJ, Bonsib SM, Amin MB, Billis A, Lopez-Beltran A, Samaratunga H, Tamboli P, Delahunt B, Egevad L, Montironi R, Srigley JR, . "Handling and staging of renal cell carcinoma: the International Society of Urological Pathology Consensus (ISUP) conference recommendations." The American journal of surgical pathology. 2013 Oct; 37(10):1505-17.
2013 Oct
Tan PH, Cheng L, Rioux-Leclercq N, Merino MJ, Netto G, Reuter VE, Shen SS, Grignon DJ, Montironi R, Egevad L, Srigley JR, Delahunt B, Moch H, . "Renal tumors: diagnostic and prognostic biomarkers." The American journal of surgical pathology. 2013 Oct; 37(10):1518-31.
2013 Sep 15
Fang LY, Izumi K, Lai KP, Liang L, Li L, Miyamoto H, Lin WJ, Chang C. "Infiltrating macrophages promote prostate tumorigenesis via modulating androgen receptor-mediated CCL4-STAT3 signaling." Cancer research. 2013 Sep 15; 73(18):5633-46. Epub 2013 Jul 22.
2013 Aug
Kakiuchi Y, Choy B, Gordetsky J, Izumi K, Wu G, Rashid H, Joseph JV, Miyamoto H. "Role of frozen section analysis of surgical margins during robot-assisted laparoscopic radical prostatectomy: a 2608-case experience." Human pathology. 2013 Aug; 44(8):1556-62. Epub 2013 Apr 02.
2013 Jun
Li Y, Zheng Y, Izumi K, Ishiguro H, Ye B, Li F, Miyamoto H. "Androgen activates ?-catenin signaling in bladder cancer cells." Endocrine-related cancer. 2013 Jun; 20(3):293-304. Epub 2013 May 20.
2013 May
Hsu JW, Hsu IW, Xu D, Miyamoto H, Liang L, Wu XR, Shyr CR, Chang C. "Decreased tumorigenesis and mortality from bladder cancer in mice lacking urothelial androgen receptor." The American journal of pathology. 2013 May; 182(5):1811-20. Epub 2013 Mar 13.
2013 May
Yang DR, Lin SJ, Ding XF, Miyamoto H, Messing E, Li LQ, Wang N, Chang C. "Higher expression of peroxisome proliferator-activated receptor ? or its activation by agonist thiazolidinedione-rosiglitazone promotes bladder cancer cell migration and invasion." Urology. 2013 May; 81(5):1109.e1-6. Epub 2013 Mar 19.
2013 Apr
Kawahara T, Ito H, Terao H, Miyamoto H, Uemura H, Kubota Y, Matsuzaki J. "Authors' response to Chew and Lange." Journal of endourology. 2013 Apr; 27(4):507. Epub 2013 Mar 15.
2013 Apr
Ishiguro Y, Ishiguro H, Miyamoto H. "Epidermal growth factor receptor tyrosine kinase inhibition up-regulates interleukin-6 in cancer cells and induces subsequent development of interstitial pneumonia." Oncotarget. 2013 Apr; 4(4):550-9.
2013 Mar
Venigalla S, Zhao C, Miyamoto H. "Histopathologic features of atypical glands on prostate biopsy: nucleolar size is a predictor of subsequent detection of prostatic adenocarcinoma." The Prostate. 2013 Mar; 73(4):376-81. Epub 2012 Aug 27.
2013 Feb
Izumi K, Zheng Y, Hsu JW, Chang C, Miyamoto H. "Androgen receptor signals regulate UDP-glucuronosyltransferases in the urinary bladder: a potential mechanism of androgen-induced bladder carcinogenesis." Molecular carcinogenesis. 2013 Feb; 52(2):94-102. Epub 2011 Nov 15.
2013
Kawahara T, Morita S, Ito H, Terao H, Sakata R, Ishiguro H, Tanaka K, Miyamoto H, Matsuzaki J, Kubota Y, Uemura H. "Ramelteon combined with an ?1-blocker decreases nocturia in men with benign prostatic hyperplasia." BMC urology. 2013 13:30. Epub 2013 Jun 12.
2013
Venigalla S, Wu G, Miyamoto H. "The impact of frozen section analysis during partial nephrectomy on surgical margin status and tumor recurrence: a clinicopathologic study of 433 cases." Clinical genitourinary cancer. 2013 11(4):527-36. Epub 2013 Jul 17.
2012 Nov
Miyamoto H, Izumi K, Yao JL, Li Y, Yang Q, McMahon LA, Gonzalez-Roibon N, Hicks DG, Tacha D, Netto GJ. "GATA binding protein 3 is down-regulated in bladder cancer yet strong expression is an independent predictor of poor prognosis in invasive tumor." Human pathology. 2012 Nov; 43(11):2033-40. Epub 2012 May 18.
2012 Nov
Izumi K, Li Y, Zheng Y, Gordetsky J, Yao JL, Miyamoto H. "Seminal plasma proteins in prostatic carcinoma: increased nuclear semenogelin I expression is a predictor of biochemical recurrence after radical prostatectomy." Human pathology. 2012 Nov; 43(11):1991-2000. Epub 2012 May 21.
2012 Nov
Izumi K, Zheng Y, Li Y, Zaengle J, Miyamoto H. "Epidermal growth factor induces bladder cancer cell proliferation through activation of the androgen receptor." International journal of oncology. 2012 Nov; 41(5):1587-92. Epub 2012 Aug 21.
2012 Nov
Zhao C, Venigalla S, Miyamoto H. "Chronic inflammation on initial benign prostate biopsy is a negative predictor of subsequent cancer detection." Pathology international. 2012 Nov; 62(11):774-6.
2012 Sep
Subik MK, Gordetsky J, Yao JL, di Sant'agnese PA, Miyamoto H. "Frozen section assessment in testicular and paratesticular lesions suspicious for malignancy: its role in preventing unnecessary orchiectomy." Human pathology. 2012 Sep; 43(9):1514-9. Epub 2012 Mar 08.
2012 Aug
Choy B, Gordetsky J, Miyamoto H. "Clinicopathologic features of prostate cancer in patients diagnosed by age 45 who underwent radical prostatectomy." European urology. 2012 Aug; 62(2):354-5. Epub 2012 May 21.
2012 Jul
Li Y, Izumi K, Miyamoto H. "The role of the androgen receptor in the development and progression of bladder cancer." Japanese journal of clinical oncology. 2012 Jul; 42(7):569-77. Epub 2012 May 15.
2012 Jun
Miyamoto H, Yao JL, Chaux A, Zheng Y, Hsu I, Izumi K, Chang C, Messing EM, Netto GJ, Yeh S. "Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder." BJU international. 2012 Jun; 109(11):1716-26. Epub 2012 Jan 05.
2012 May
Subik MK, Yao JL, di Sant'agnese PA, Miyamoto H. "The role of periprostatic and periseminal vesicle lymph node metastasis in the staging and prognosis of prostate cancer." Histopathology. 2012 May; 60(6):1009-10. Epub 2012 Feb 28.
2012 Jan
Chaux A, Karram S, Miller JS, Fajardo DA, Lee TK, Miyamoto H, Netto GJ. "High-grade papillary urothelial carcinoma of the urinary tract: a clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic center." Human pathology. 2012 Jan; 43(1):115-20. Epub 2011 Aug 04.
2012 Jan
Miyamoto H, Zheng Y, Izumi K. "Nuclear hormone receptor signals as new therapeutic targets for urothelial carcinoma." Current cancer drug targets. 2012 Jan; 12(1):14-22.
2012 Jan
Yamashita S, Lai KP, Chuang KL, Xu D, Miyamoto H, Tochigi T, Pang ST, Li L, Arai Y, Kung HJ, Yeh S, Chang C. "ASC-J9 suppresses castration-resistant prostate cancer growth through degradation of full-length and splice variant androgen receptors." Neoplasia : an international journal for oncology research. 2012 Jan; 14(1):74-83.
2012
Choy B, Gordetsky J, Varghese M, Lloyd GL, Wu G, Miyamoto H. "Mixed epithelial and stromal tumor of the kidney in a 14-year-old boy." Urologia internationalis. 2012 88(2):247-8. Epub 2012 Jan 10.
2012
Zheng Y, Izumi K, Li Y, Ishiguro H, Miyamoto H. "Contrary regulation of bladder cancer cell proliferation and invasion by dexamethasone-mediated glucocorticoid receptor signals." Molecular cancer therapeutics. 2012 11(12):2621-32. Epub 2012 Oct 01.
2011 Nov
Lee TK, Chaux A, Karram S, Miyamoto H, Miller JS, Fajardo DA, Epstein JI, Netto GJ. "Papillary urothelial neoplasm of low malignant potential of the urinary bladder: clinicopathologic and outcome analysis from a single academic center." Human pathology. 2011 Nov; 42(11):1799-803.
2011 Nov
Fajardo DA, Miyamoto H, Miller JS, Lee TK, Epstein JI. "Identification of Gleason pattern 5 on prostatic needle core biopsy: frequency of underdiagnosis and relation to morphology." The American journal of surgical pathology. 2011 Nov; 35(11):1706-11.
2011 Aug
Zheng Y, Izumi K, Yao JL, Miyamoto H. "Dihydrotestosterone upregulates the expression of epidermal growth factor receptor and ERBB2 in androgen receptor-positive bladder cancer cells." Endocrine-related cancer. 2011 Aug; 18(4):451-64. Epub 2011 Jul 04.
2011 Aug
Gordetsky J, Findeis-Hosey J, Erturk E, Messing EM, Yao JL, Miyamoto H. "Role of frozen section analysis of testicular/paratesticular fibrous pseudotumours: a five-case experience." Canadian Urological Association journal = Journal de l'Association des urologues du Canada. 2011 Aug; 5(4):E47-51.
2011 Jul
Mir C, Shariat SF, Van Der Kwast TH, Ashfaq R, Lotan Y, Evans A, Skeldon S, Hanna S, Vajpeyi R, Kuk C, Alkhateeb S, Morote J, Van Rhijn BW, Bostrom P, Yao J, Miyamoto H, Jewett M, Fleshner N, Messing E, Zlotta AR. "Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: a large multi-institutional study." BJU international. 2011 Jul; 108(1):24-30. Epub 2010 Nov 10.
2011 Jul
Canacci AM, Izumi K, Zheng Y, Gordetsky J, Yao JL, Miyamoto H. "Expression of semenogelins I and II and its prognostic significance in human prostate cancer." The Prostate. 2011 Jul; 71(10):1108-14. Epub 2010 Dec 28.
2011 Jun
Izumi K, Zheng Y, Miyamoto H. "Eppin expression in prostate cancer." European urology. 2011 Jun; 59(6):1071-2.
2010 Sep
Miyamoto H, Epstein JI. "Transurethral resection specimens of the bladder: outcome of invasive urothelial cancer involving muscle bundles indeterminate between muscularis mucosae and muscularis propria." Urology. 2010 Sep; 76(3):600-2. Epub 2010 Apr 14.
2010 Aug
Miyamoto H, Brimo F, Schultz L, Ye H, Miller JS, Fajardo DA, Lee TK, Epstein JI, Netto GJ. "Low-grade papillary urothelial carcinoma of the urinary bladder: a clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic center." Archives of pathology & laboratory medicine. 2010 Aug; 134(8):1160-3.
2010 Apr
Lee TK, Miyamoto H, Osunkoya AO, Guo CC, Weiss SW, Epstein JI. "Smooth muscle neoplasms of the urinary bladder: a clinicopathologic study of 51 cases." The American journal of surgical pathology. 2010 Apr; 34(4):502-9.
2010 Apr
Miyamoto H, Montgomery EA, Epstein JI. "Paratesticular fibrous pseudotumor: a morphologic and immunohistochemical study of 13 cases." The American journal of surgical pathology. 2010 Apr; 34(4):569-74.
2010 Mar
Miyamoto H, Sharma RB, Illei PB, Epstein JI. "Pitfalls in the use of smoothelin to identify muscularis propria invasion by urothelial carcinoma." The American journal of surgical pathology. 2010 Mar; 34(3):418-22.
2010 Jan
Miyamoto H, Miller JS, Fajardo DA, Lee TK, Netto GJ, Epstein JI. "Non-invasive papillary urothelial neoplasms: the 2004 WHO/ISUP classification system." Pathology international. 2010 Jan; 60(1):1-8.
2009 Nov
Duffield AS, Lee TK, Miyamoto H, Carter HB, Epstein JI. "Radical prostatectomy findings in patients in whom active surveillance of prostate cancer fails." The Journal of urology. 2009 Nov; 182(5):2274-8. Epub 2009 Sep 16.
2009 Oct
Tavora F, Fajardo DA, Lee TK, Lotan T, Miller JS, Miyamoto H, Epstein JI. "Small endoscopic biopsies of the ureter and renal pelvis: pathologic pitfalls." The American journal of surgical pathology. 2009 Oct; 33(10):1540-6.
2009 Jan
Ohta S, Uemura H, Matsui Y, Ishiguro H, Fujinami K, Kondo K, Miyamoto H, Yazawa T, Danenberg K, Danenberg PV, Tohnai I, Kubota Y. "Alterations of p16 and p14ARF genes and their 9p21 locus in oral squamous cell carcinoma." Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics. 2009 Jan; 107(1):81-91.
2009
Miyamoto H, Jones CE, Raymond DP, Wandtke JC, Strang JG, Bourne PA, Bonfiglio TA, Xu H. "Pulmonary metastases from uterine neoplasms after long tumour-free interval: four cases and review of the literature." Pathology. 2009 41(3):234-41.
2009
Miyamoto H, Hernandez DJ, Epstein JI. "A pathological reassessment of organ-confined, Gleason score 6 prostatic adenocarcinomas that progress after radical prostatectomy." Human pathology. 2009 40(12):1693-8. Epub 2009 Aug 14.
2008 Sep 1
Niu Y, Yeh S, Miyamoto H, Li G, Altuwaijri S, Yuan J, Han R, Ma T, Kuo HC, Chang C. "Tissue prostate-specific antigen facilitates refractory prostate tumor progression via enhancing ARA70-regulated androgen receptor transactivation." Cancer research. 2008 Sep 1; 68(17):7110-9.
2008 Feb
Singer EA, Golijanin DJ, Miyamoto H, Messing EM. "Androgen deprivation therapy for prostate cancer." Expert opinion on pharmacotherapy. 2008 Feb; 9(2):211-28.
2008
Johnson AM, O'Connell MJ, Miyamoto H, Huang J, Yao JL, Messing EM, Reeder JE. "Androgenic dependence of exophytic tumor growth in a transgenic mouse model of bladder cancer: a role for thrombospondin-1." BMC urology. 2008 8:7. Epub 2008 Apr 23.
2007 Jul
Miyamoto H, Molena DA, Schoeniger LO, Haodong Xu . "Solitary fibrous tumor of the pancreas: a case report." International journal of surgical pathology. 2007 Jul; 15(3):311-4.
2007 Apr 4
Miyamoto H, Yang Z, Chen YT, Ishiguro H, Uemura H, Kubota Y, Nagashima Y, Chang YJ, Hu YC, Tsai MY, Yeh S, Messing EM, Chang C. "Promotion of bladder cancer development and progression by androgen receptor signals." Journal of the National Cancer Institute. 2007 Apr 4; 99(7):558-68.
2007 Mar
Yang Z, Chang YJ, Miyamoto H, Yeh S, Yao JL, di Sant'Agnese PA, Tsai MY, Chang C. "Suppression of androgen receptor transactivation and prostate cancer cell growth by heterogeneous nuclear ribonucleoprotein A1 via interaction with androgen receptor coregulator ARA54." Endocrinology. 2007 Mar; 148(3):1340-9. Epub 2006 Nov 16.
2007 Mar
Yang Z, Chang YJ, Yu IC, Yeh S, Wu CC, Miyamoto H, Merry DE, Sobue G, Chen LM, Chang SS, Chang C. "ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor." Nature medicine. 2007 Mar; 13(3):348-53. Epub 2007 Mar 04.
2007 Feb
Yang Z, Chang YJ, Miyamoto H, Ni J, Niu Y, Chen Z, Chen YL, Yao JL, di Sant'Agnese PA, Chang C. "Transgelin functions as a suppressor via inhibition of ARA54-enhanced androgen receptor transactivation and prostate cancer cell growth." Molecular endocrinology. 2007 Feb; 21(2):343-58. Epub 2006 Nov 02.
2007 Feb
Fujimoto N, Miyamoto H, Mizokami A, Harada S, Nomura M, Ueta Y, Sasaguri T, Matsumoto T. "Prostate cancer cells increase androgen sensitivity by increase in nuclear androgen receptor and androgen receptor coactivators; a possible mechanism of hormone-resistance of prostate cancer cells." Cancer investigation. 2007 Feb; 25(1):32-7.
2006 Sep 1
Marwah P, Marwah A, Lardy HA, Miyamoto H, Chang C. "C19-steroids as androgen receptor modulators: design, discovery, and structure-activity relationship of new steroidal androgen receptor antagonists." Bioorganic & medicinal chemistry. 2006 Sep 1; 14(17):5933-47. Epub 2006 Jun 08.
2005 Sep
Miyamoto H, Altuwaijri S, Cai Y, Messing EM, Chang C. "Inhibition of the Akt, cyclooxygenase-2, and matrix metalloproteinase-9 pathways in combination with androgen deprivation therapy: potential therapeutic approaches for prostate cancer." Molecular carcinogenesis. 2005 Sep; 44(1):1-10.
2005 May
Miyamoto H, Messing EM, Chang C. "Does androgen deprivation improve treatment outcomes in patients with low-risk and intermediate-risk prostate cancer?" Nature clinical practice. Oncology. 2005 May; 2(5):236-7.
2005
Miyamoto H, Marwah P, Marwah A, Yang Z, Chung CY, Altuwaijri S, Chang C, Lardy H. "Identification of steroid derivatives that function as potent antiandrogens." International journal of cancer. 2005 117(5):866-72.
2004 Jun
Miyamoto H, Messing EM. "Early versus late hormonal therapy for prostate cancer." Current urology reports. 2004 Jun; 5(3):188-96.
2004 Apr 1
Rahman M, Miyamoto H, Chang C. "Androgen receptor coregulators in prostate cancer: mechanisms and clinical implications." Clinical cancer research : an official journal of the American Association for Cancer Research. 2004 Apr 1; 10(7):2208-19.
2004 Jan 1
Miyamoto H, Rahman MM, Chang C. "Molecular basis for the antiandrogen withdrawal syndrome." Journal of cellular biochemistry. 2004 Jan 1; 91(1):3-12.
2004
Miyamoto H, Messing EM, Chang C. "Androgen deprivation therapy for prostate cancer: current status and future prospects." The Prostate. 2004 61(4):332-53.
2003 Sep 1
Miyoshi Y, Ishiguro H, Uemura H, Fujinami K, Miyamoto H, Miyoshi Y, Kitamura H, Kubota Y. "Expression of AR associated protein 55 (ARA55) and androgen receptor in prostate cancer." The Prostate. 2003 Sep 1; 56(4):280-6.
2003 Aug 15
Nishimura K, Ting HJ, Harada Y, Tokizane T, Nonomura N, Kang HY, Chang HC, Yeh S, Miyamoto H, Shin M, Aozasa K, Okuyama A, Chang C. "Modulation of androgen receptor transactivation by gelsolin: a newly identified androgen receptor coregulator." Cancer research. 2003 Aug 15; 63(16):4888-94.
2003 May 30
Rahman MM, Miyamoto H, Takatera H, Yeh S, Altuwaijri S, Chang C. "Reducing the agonist activity of antiandrogens by a dominant-negative androgen receptor coregulator ARA70 in prostate cancer cells." The Journal of biological chemistry. 2003 May 30; 278(22):19619-26. Epub 2003 Mar 20.
2003 Apr 29
Rahman MM, Miyamoto H, Lardy H, Chang C. "Inactivation of androgen receptor coregulator ARA55 inhibits androgen receptor activity and agonist effect of antiandrogens in prostate cancer cells." Proceedings of the National Academy of Sciences of the United States of America. 2003 Apr 29; 100(9):5124-9. Epub 2003 Apr 16.
2003 Apr 15
Miyamoto H, Marwah P, Marwah A, Lardy H, Chang C. "3 beta-acetoxyandrost-1,5-diene-17-ethylene ketal functions as a potent antiandrogen with marginal agonist activity." Proceedings of the National Academy of Sciences of the United States of America. 2003 Apr 15; 100(8):4440-4. Epub 2003 Apr 02.
2002 Feb 15
Miyamoto H, Rahman M, Takatera H, Kang HY, Yeh S, Chang HC, Nishimura K, Fujimoto N, Chang C. "A dominant-negative mutant of androgen receptor coregulator ARA54 inhibits androgen receptor-mediated prostate cancer growth." The Journal of biological chemistry. 2002 Feb 15; 277(7):4609-17. Epub 2001 Oct 22.
2000 May
Miyamoto H, Kubota Y, Noguchi S, Takase K, Matsuzaki J, Moriyama M, Takebayashi S, Kitamura H, Hosaka M. "C-ERBB-2 gene amplification as a prognostic marker in human bladder cancer." Urology. 2000 May; 55(5):679-83.
2000 Jan
Miyamoto H, Chang C. "Antiandrogens fail to block androstenedione-mediated mutated androgen receptor transactivation in human prostate cancer cells." International journal of urology : official journal of the Japanese Urological Association. 2000 Jan; 7(1):32-4.
1999 Nov 26
Miyamoto H, Miyagi Y, Ishikawa T, Ichikawa Y, Hosaka M, Kubota Y. "DNA polymerase beta gene mutation in human breast cancer." International journal of cancer. 1999 Nov 26; 83(5):708-9.
1999 Oct
Yeh S, Kang HY, Miyamoto H, Nishimura K, Chang HC, Ting HJ, Rahman M, Lin HK, Fujimoto N, Hu YC, Mizokami A, Huang KE, Chang C. "Differential induction of androgen receptor transactivation by different androgen receptor coactivators in human prostate cancer DU145 cells." Endocrine. 1999 Oct; 11(2):195-202.
1999 Sep 28
Chang HC, Miyamoto H, Marwah P, Lardy H, Yeh S, Huang KE, Chang C. "Suppression of Delta(5)-androstenediol-induced androgen receptor transactivation by selective steroids in human prostate cancer cells." Proceedings of the National Academy of Sciences of the United States of America. 1999 Sep 28; 96(20):11173-7.
1999 Jun
Yeh S, Chang HC, Miyamoto H, Takatera H, Rahman M, Kang HY, Thin TH, Lin HK, Chang C. "Differential induction of the androgen receptor transcriptional activity by selective androgen receptor coactivators." The Keio journal of medicine. 1999 Jun; 48(2):87-92.
1998 Sep 15
Miyamoto H, Yeh S, Lardy H, Messing E, Chang C. "Delta5-androstenediol is a natural hormone with androgenic activity in human prostate cancer cells." Proceedings of the National Academy of Sciences of the United States of America. 1998 Sep 15; 95(19):11083-8.
1998 Jul 20
Yeh S, Miyamoto H, Nishimura K, Kang H, Ludlow J, Hsiao P, Wang C, Su C, Chang C. "Retinoblastoma, a tumor suppressor, is a coactivator for the androgen receptor in human prostate cancer DU145 cells." Biochemical and biophysical research communications. 1998 Jul 20; 248(2):361-7.
1998 Jun 23
Miyamoto H, Yeh S, Wilding G, Chang C. "Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells." Proceedings of the National Academy of Sciences of the United States of America. 1998 Jun 23; 95(13):7379-84.
1998 May 12
Yeh S, Miyamoto H, Shima H, Chang C. "From estrogen to androgen receptor: a new pathway for sex hormones in prostate." Proceedings of the National Academy of Sciences of the United States of America. 1998 May 12; 95(10):5527-32.
1998
Takeda M; Noguchi K; Masuda M; Yao M; Kinoshita Y; Hosaka M; et al.; Shiozaki H; Miyamoto H. "Comparative study on morning and evening regimens of fleroxacin (FLRX) for the treatment of complicated urinary tract infections". Nishinihon Journal of Urology. 1998; 60(10): 733-744.
1997 Aug
Hayashi H, Miyamoto H, Ito T, Kameda Y, Nakamura N, Kubota Y, Kitamura H. "Analysis of p21Waf1/Cip1 expression in normal, premalignant, and malignant cells during the development of human lung adenocarcinoma." The American journal of pathology. 1997 Aug; 151(2):461-70.
1997 Mar 22
Yeh S, Miyamoto H, Chang C. "Hydroxyflutamide may not always be a pure antiandrogen." Lancet. 1997 Mar 22; 349(9055):852-3.
1996 Jun
Miyamoto H, Kubota Y, Shuin T, Shiozaki H. "Bilateral adrenocortical carcinoma showing loss of heterozygosity at the p53 and RB gene loci." Cancer genetics and cytogenetics. 1996 Jun; 88(2):181-3.
1996 Jun
Lin Y, Miyamoto H, Fujinami K, Uemura H, Hosaka M, Iwasaki Y, Kubota Y. "Telomerase activity in human bladder cancer." Clinical cancer research : an official journal of the American Association for Cancer Research. 1996 Jun; 2(6):929-32.
1996 Apr
Miyamoto H, Shuin T, Ikeda I, Hosaka M, Kubota Y. "Loss of heterozygosity at the p53, RB, DCC and APC tumor suppressor gene loci in human bladder cancer." The Journal of urology. 1996 Apr; 155(4):1444-7.
1996 Jan
Matsuzaki J, Dobashi Y, Miyamoto H, Ikeda I, Fujinami K, Shuin T, Kubota Y. "DNA polymerase beta gene mutations in human bladder cancer." Molecular carcinogenesis. 1996 Jan; 15(1):38-43.
1995 Aug
Kubota Y, Miyamoto H, Noguchi S, Shuin T, Kitamura H, Xu HJ, Hu SX, Benedict WF. "The loss of retinoblastoma gene in association with c-myc and transforming growth factor-beta 1 gene expression in human bladder cancer." The Journal of urology. 1995 Aug; 154(2 Pt 1):371-4.
1995 Jul
Kubota Y, Shuin T, Uemura H, Fujinami K, Miyamoto H, Torigoe S, Dobashi Y, Kitamura H, Iwasaki Y, Danenberg K. "Tumor suppressor gene p53 mutations in human prostate cancer." The Prostate. 1995 Jul; 27(1):18-24.
1995 May 15
Miyamoto H, Kubota Y, Shuin T, Torigoe S, Dobashi Y, Hosaka M. "Expression of transforming growth factor-beta 1 in human bladder cancer." Cancer. 1995 May 15; 75(10):2565-70.
1995 Apr
Miyamoto H, Shuin T, Torigoe S, Iwasaki Y, Kubota Y. "Retinoblastoma gene mutations in primary human bladder cancer." British journal of cancer. 1995 Apr; 71(4):831-5.
1995
Kubota Y, Fujinami K, Uemura H, Dobashi Y, Miyamoto H, Iwasaki Y, Kitamura H, Shuin T. "Retinoblastoma gene mutations in primary human prostate cancer." The Prostate. 1995 27(6):314-20.
1995
Miyamoto H, Kubota Y, Fujinami K, Dobashi Y, Kondo K, Yao M, Shuin T, Hosaka M. "Infrequent somatic mutations of the p16 and p15 genes in human bladder cancer: p16 mutations occur only in low-grade and superficial bladder cancers." Oncology research. 1995 7(7-8):327-30.
1994 May
Miyamoto H, Usuda K. "[Spontaneous rupture of the hydronephrotic renal parenchyma associated with urinoma in a child]." Hinyokika kiyo. Acta urologica Japonica. 1994 May; 40(5):419-21.
1994 Jan
Miyamoto H, Moriyama M, Fukushima S, Nakamura N, Kameda Y. "Retroperitoneal tumor eleven years after initial treatment of testicular cancer." Urology. 1994 Jan; 43(1):116-7.
1994
Kubota Y; Miyamoto H; Uemura H; Fujinami K; Shuin T. "Oncogenes and tumor suppressor genes in human urogenital cancers". Japanese Journal of Clinical Urology. 1994; 48(3): 185-194.
1994
Kubota Y; Shuin T; Noguchi S; Ishibashi Y; Miyamoto H; Yao M; Hosaka M; Miura T. "Prophylactic intravesical chemotherapy with 4'-epirubicin in recurrent superficial bladder cancer". Regional Cancer Treatment. 1994; 7: 193-196.
1993 Jun
Fukushima S, Moriyama M, Miyamoto H. "[Experience with extracorporeal shock wave lithotripsy in children]." Hinyokika kiyo. Acta urologica Japonica. 1993 Jun; 39(6):507-9.
1993 May
Moriyama M, Nomura S, Miyamoto H, Fukushima S. "[Clinical trial of the systemic chemotherapy for advanced prostatic cancer patients]." Gan to kagaku ryoho. Cancer & chemotherapy. 1993 May; 20(7):969-71.
1993
Noguchi S; Kubota Y; Shuin T; Miyamoto H; et al. "Clinical observations on bladder cancer - difference in clinical features with age". Acta Urologica Japonica. 1993; 39(12): 1131-1138.
1993
Kubota Y; Miyamoto H; Shuin T; Kitamura H. "Oncogenes and tumor suppressor genes in human bladder cancer". Japanese Journal of Urological Surgery. 1993; 6(6): 495-500.
1993
Miyamoto H; Moriyama M; Fukushima S. "Spontaneous peripelvic extravasation: Report of two cases". Japanese Journal of Urological Surgery. 1993; 6(6): 565-569.
1993
Usuda K; Miyamoto H; Hasegawa T; Shimura K. "Cryptorchism and chromosomal abnormalities (Edwards, Patau, Lowe syndrome)". Nippon-rinsho Naibunptsuishokogun. 1993; : 888-891.
1993
Miyamoto H, Kubota Y, Shuin T, Torigoe S, Hosaka M, Iwasaki Y, Danenberg K, Danenberg PV. "Analyses of p53 gene mutations in primary human bladder cancer." Oncology research. 1993 5(6-7):245-9.
1992 Jul
Miyamoto H, Miura T, Noguchi S, Shuin T, Kubota Y, Hosaka M. "[A clinical study of 115 patients with testicular tumor]." Hinyokika kiyo. Acta urologica Japonica. 1992 Jul; 38(7):797-802.
1992 Apr
Fukushima S, Moriyama M, Miyamoto H, Hosaka M, Kubota Y, Kinoshita Y, Noguchi K, Shuin T, Noguchi S, Yoshimura S. "[Clinical studies on tosufloxacin (TFLX) in urology]." Hinyokika kiyo. Acta urologica Japonica. 1992 Apr; 38(4):501-6.
1992
Miyamoto H; Moriyama M; Fukushima S. "Renal oncocytoma with malignant features". Japanese Journal of Urological Surgery. 1992; 5(4): 341-343.
1992
Miyamoto H; Moriyama M; Fukushima S. "Clinical application of tissue adhesive agent (Fibrin glue) in the field of Urology - Studies on testicular hydrocele". Japanese Journal of Clinical Urology. 1992; 46(9): 749-751.
1992
Miyamoto H; Sekiguchi Y; Moriyama M; Fukushima S. "Clinical application of tissue adhesive agent (Fibrin glue) in gaping of postoperative wound". Journal of New Remedies & Clinics. 1992; 41(8): 1941-1943.
1992
Fukushima S; Moriyama M; Miyamoto H; et al. "Clinical studies on Sulbactam/Cefoperazone in Urology". The Japanese Journal of Clinical and Experimental Medicine. 1992; 69(11): 3709-3714.
1992
Fukushima S; Moriyama M; Miyamoto H; et al. "Clinical studies on lomefloxacin (LFLX) for treatment of acute uncomplicated cystitis". Nishinihon Journal of Urology. 1992; 54(12): 2295-2301.
1992
Miyamoto H, Kuwamitsu O, Moriyama M, Sakanishi S, Fujii H, Fukushima S, Sano J, Oaki Y. "Bellini duct carcinoma of the kidney." Urologia internationalis. 1992 48(4):460-2.
1991
Miyamoto H; Moriyama M; Fukushima S. "A case of renal pelvic cancer with lung metastasis showing complete remission by MEC (Methotrexate, Etoposide, Cisplatin) therapy". The Clinical Report. 1991; 25(5): 1961-1963.
1991
Kubota Y; Shuin T; Misaki H; Yao M; Miyamoto H; Uemura H. "Oncogenes and urogenital cancers". KARKINOS. 1991; 4(3): 289-299.
1991
Miyamoto H; Moriyama M; Fukushima S. "An effective case of combination therapy with interferon ? and ? in advanced renal cell carcinoma". Biotherapy. 1991; 5(11): 1827-1829.
1990
Miyamoto H, Iizawa H, Takahashi T, Miura T, Kinoshita Y, Kubota Y, Hosaka M. "[An effective case of M-VAC therapy of advanced bladder cancer with extramammary Paget's disease]." Hinyokika kiyo. Acta urologica Japonica. 1990 36(12):1459-62.

Books

2015
Miyamoto H; Shen SS. "Intraoperative consultation for prostate tumors: Challenges and implications for treatment". Genitourinary Pathology: Practical Advances. Magi-Galluzzi C; Przybycin CG. New York: Springer, 2015. 145-148
2015
Miyamoto H, Shen SS. "Intraoperative consultation for bladder tumors: Challenges and implications for treatment". Genitourinary Pathology: Practical Advances. Magi-Galluzzi C; Przybycin CG. New York: Springer, 2015. 247-251
2015
Miyamoto H; Shen SS. "Intraoperative consultation for renal tumors: Challenges and implications for treatment". Genitourinary Pathology: Practical Advances. Magi-Galluzzi C; Przybycin CG. New York: Springer, 2015. 401-405
2015
Miyamoto H; Shen SS. "Intraoperative consultation for testicular tumors: Challenges and implications for treatment". Genitourinary Pathology: Practical Advances. Magi-Galluzzi C; Przybycin CG. New York: Springer, 2015. 517-520
2013
Ishiguro H; Kawahara T; Li Y; Miyamoto H. "Anti-tumor activities of dexamethasone". Dexamethasone: Therapeutic Uses, Mechanism of Action and Potential Side Effects. Sauvage A; Levy M. Hauppauge, New York: Nova Science Publishers, 2013. 117-135
2013
Kawahara T; Ito H; Miyamoto H; Uemura H; Kubota Y; Matsuzaki J. "Endoscopic management of urolithiasis". Ureters: Anatomy, Physiology and Disorders. Santucci RA; Chen M. Hauppauge, New York: Nova Science Publishers, 2013. 29-52
2012
Miyamoto H. "Urine-based assays complementing cytologic examination in the detection of urothelial neoplasm". Koss's Cytology of the Urinary Tract with Histopathologic Correlations. Koss LG, Hoda RS. New York: Springer, 2012. 109-121
2012
Miyamoto H. "Differentiation between muscularis mucosae and muscularis propria". Atlas Series of Differential Diagnosis of Tumor Histopathology: Renal Pelvis/Ureter/ Bladder Cancer. Tsuzuki T, Morinaga S. Tokyo: Bunkodo, 2012. 138-146
2009
Yeh S; Niu Y; Miyamoto H; Chang T; Chang C. "Differential roles of androgen receptor in prostate development and cancer progression". Androgen Action in Prostate Cancer. Tindall D; Mohler J. New York: Springer, 2009. 73-89
2008
Miyamoto H; Altuwaijri S; Chang C. "Androgen receptor in prostate cancer progression". Current Clinical Oncology: Prostate Cancer: Signaling Networks, Genetics, and New Treatment Strategies. Pestell RG; Nevalainen MT. Totowa, New Jersey: Humana Press, 2008. 129-146
2005
Miyamoto H. "Hormonal therapy for prostate cancer: Clinical and experimental evidence". Prostate Cancer – Basic Mechanisms and Therapeutic Approaches. Chang C. Hackensack, New Jersey: World Scientific, 2005.
2002
Sampson ER; Yeh S; Miyamoto H; Lee DK; Tsai M-Y; Wang X; Hsu CL; Chang C. "Interaction of cell cycle regulatory proteins with the androgen receptor". Steroid Hormones and Cell Cycle Regulation. Burnstein KL. Norwell, Massachusetts: Kluwer Academic Publishers, 2002. 223-238
1998
Miyamoto H; Yeh S; Hwang S-B; Fujimoto N; Hsiao P; Ting H; Nishimura K; Wang C; Inui S; Uemura H; Kang H; Chang C. "The androgen receptor co-regulator, ARA70". Molecular Basis of Sex Hormone Receptor Function – New Targets for Intervention. Gronemeyer H; Fuhrmann U; Parczyk K. Berlin: Springer, 1998. 43-51
1997
Miyamoto H; Yeh S; Kinoshita H; Fujimoto N; Nishimura K; Inui S; Mizokami A; Uemura H; Chang C. "Androgen receptor and androgen receptor cofactors in prostate". Proceedings of National Conference of the Japan Society of Andrology. Hosaka M. : Blackwell Publishing, 1997. 1-4
1994
Kubota Y; Fujinami K; Uemura H; Miyamoto H; Dobashi Y; Shuin T; Hosaka M; Iwasaki Y; Kitamura H. "Analysis of tumor suppressor genes in human prostate cancer by RNA-SSCP method". Fundamental Approaches to the Diagnosis and Treatment of Prostate Cancer and BPH. Imai K; Shimazaki J; Karr JP. Tokyo: Adenine Press, 1994. 157-168